サマリー

BRAFキナーゼ阻害剤の世界市場 2022-2026 年
Technavioは、BRAFキナーゼ阻害剤市場を監視しており、2022-2026年の間に11億9000万ドルの成長が見込まれ、予測期間中にCAGR7.73%で加速しています。当レポートでは、ブラフキナーゼ阻害剤市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。BRAFキナーゼ阻害剤の高い標的親和性と特異性、患者支援プログラムの存在、がんの有病率の上昇などが市場を牽引しています。
BRAFキナーゼ阻害剤市場の分析には、製品セグメントと地理的展望が含まれます。
TechnavioのBRAFキナーゼ阻害剤市場は、以下のようにセグメント化されています。
製品別
- ダブラフェニブ
- ソラフェニブ
- ベムラフェニブ
- エンコラフェニブ
地域別状況
- 北アメリカ
- アジア
- ヨーロッパ
- その他の地域 (ROW)
本研究では、今後数年間におけるブラフキナーゼ阻害剤市場の成長を促進する主要な理由の一つとして、研究分野の拡大を挙げています。また、戦略的提携や癌に対する意識の高まりは、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ブラフキナーゼ阻害剤市場に関する当レポートの対象領域は以下の通りです。
- ブラフキナーゼ阻害剤市場のサイジング
- ブラフキナーゼ阻害剤の市場予測
- ブラフキナーゼ阻害剤市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Asana BioSciences LLC、Bayer AG、BeiGene Ltd.、F. Hoffmann La Roche Ltd.、Novartis AG、Ono Pharmaceutical Co.ホフマン・ラ・ロシュ社、ノバルティス社、小野薬品工業社、ファイザー社、ピエール・ファーブル社などです。また、ブラフキナーゼ阻害剤市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/braf-kinase-inhibitors-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Dabrafenib - Market size and forecast 2021-2026
o Exhibit 28: Chart on Dabrafenib - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Dabrafenib - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Dabrafenib - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Dabrafenib - Year-over-year growth 2021-2026 (%)
o 5.4 Sorafenib - Market size and forecast 2021-2026
o Exhibit 32: Chart on Sorafenib - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Sorafenib - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Sorafenib - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Sorafenib - Year-over-year growth 2021-2026 (%)
o 5.5 Vemurafenib - Market size and forecast 2021-2026
o Exhibit 36: Chart on Vemurafenib - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Vemurafenib - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Vemurafenib - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Vemurafenib - Year-over-year growth 2021-2026 (%)
o 5.6 Encorafenib - Market size and forecast 2021-2026
o Exhibit 40: Chart on Encorafenib - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Encorafenib - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Encorafenib - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Encorafenib - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Product
o Exhibit 44: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.5 Europe - Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.9 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.10 Denmark - Market size and forecast 2021-2026
o Exhibit 78: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Denmark - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 Asana BioSciences LLC
o Exhibit 93: Asana BioSciences LLC - Overview
o Exhibit 94: Asana BioSciences LLC - Product / Service
o Exhibit 95: Asana BioSciences LLC - Key offerings
o 10.4 Bayer AG
o Exhibit 96: Bayer AG - Overview
o Exhibit 97: Bayer AG - Business segments
o Exhibit 98: Bayer AG - Key offerings
o Exhibit 99: Bayer AG - Segment focus
o 10.5 BeiGene Ltd.
o Exhibit 100: BeiGene Ltd. - Overview
o Exhibit 101: BeiGene Ltd. - Business segments
o Exhibit 102: BeiGene Ltd. - Key offerings
o Exhibit 103: BeiGene Ltd. - Segment focus
o 10.6 F. Hoffmann La Roche Ltd.
o Exhibit 104: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 105: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 106: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 107: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 108: F. Hoffmann La Roche Ltd. - Segment focus
o 10.7 Novartis AG
o Exhibit 109: Novartis AG - Overview
o Exhibit 110: Novartis AG - Business segments
o Exhibit 111: Novartis AG - Key offerings
o Exhibit 112: Novartis AG - Segment focus
o 10.8 Ono Pharmaceutical Co. Ltd.
o Exhibit 113: Ono Pharmaceutical Co. Ltd. - Overview
o Exhibit 114: Ono Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 115: Ono Pharmaceutical Co. Ltd. - Key offerings
o 10.9 Pfizer Inc.
o Exhibit 116: Pfizer Inc. - Overview
o Exhibit 117: Pfizer Inc. - Product / Service
o Exhibit 118: Pfizer Inc. - Key news
o Exhibit 119: Pfizer Inc. - Key offerings
o 10.10 Pierre Fabre SA
o Exhibit 120: Pierre Fabre SA - Overview
o Exhibit 121: Pierre Fabre SA - Business segments
o Exhibit 122: Pierre Fabre SA - Key offerings
o Exhibit 123: Pierre Fabre SA - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Dabrafenib - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Dabrafenib - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Dabrafenib - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Dabrafenib - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Sorafenib - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Sorafenib - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Sorafenib - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Sorafenib - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Vemurafenib - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Vemurafenib - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Vemurafenib - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Vemurafenib - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Encorafenib - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Encorafenib - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Encorafenib - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Encorafenib - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Asana BioSciences LLC - Overview
Exhibits94: Asana BioSciences LLC - Product / Service
Exhibits95: Asana BioSciences LLC - Key offerings
Exhibits96: Bayer AG - Overview
Exhibits97: Bayer AG - Business segments
Exhibits98: Bayer AG - Key offerings
Exhibits99: Bayer AG - Segment focus
Exhibits100: BeiGene Ltd. - Overview
Exhibits101: BeiGene Ltd. - Business segments
Exhibits102: BeiGene Ltd. - Key offerings
Exhibits103: BeiGene Ltd. - Segment focus
Exhibits104: F. Hoffmann La Roche Ltd. - Overview
Exhibits105: F. Hoffmann La Roche Ltd. - Business segments
Exhibits106: F. Hoffmann La Roche Ltd. - Key news
Exhibits107: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits108: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits109: Novartis AG - Overview
Exhibits110: Novartis AG - Business segments
Exhibits111: Novartis AG - Key offerings
Exhibits112: Novartis AG - Segment focus
Exhibits113: Ono Pharmaceutical Co. Ltd. - Overview
Exhibits114: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibits115: Ono Pharmaceutical Co. Ltd. - Key offerings
Exhibits116: Pfizer Inc. - Overview
Exhibits117: Pfizer Inc. - Product / Service
Exhibits118: Pfizer Inc. - Key news
Exhibits119: Pfizer Inc. - Key offerings
Exhibits120: Pierre Fabre SA - Overview
Exhibits121: Pierre Fabre SA - Business segments
Exhibits122: Pierre Fabre SA - Key offerings
Exhibits123: Pierre Fabre SA - Segment focus
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations